Insider Selling: Amicus Therapeutics, Inc. (NASDAQ:FOLD) CEO Sells 7,500 Shares of Stock
Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) CEO Bradley L. Campbell sold 7,500 shares of Amicus Therapeutics stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $11.71, for a total value of $87,825.00. Following the sale, the chief executive officer now owns 886,654 shares of the […]
More Stories
Ibstock (LON:IBST) Stock Price Passes Below 50 Day Moving Average – Should You Sell?
Ibstock plc (LON:IBST – Get Free Report) passed below its 50-day moving average during trading on Wednesday . The stock...
Templeton Emerging Markets Investment Trust (LON:TEM) Share Price Passes Below Fifty Day Moving Average – Time to Sell?
Templeton Emerging Markets Investment Trust plc (LON:TEM – Get Free Report)’s share price crossed below its 50-day moving average during...
Transat A.T. (TSE:TRZ) Stock Crosses Below 50 Day Moving Average – Here’s Why
Transat A.T. Inc. (TSE:TRZ – Get Free Report) crossed below its 50 day moving average during trading on Wednesday ....
Tilly’s (NYSE:TLYS) Stock Crosses Below 50-Day Moving Average – Time to Sell?
Tilly’s, Inc. (NYSE:TLYS – Get Free Report) shares passed below its fifty day moving average during trading on Wednesday ....
Invesco Income Growth Trust (LON:IVI) Stock Passes Below Fifty Day Moving Average – Should You Sell?
Invesco Income Growth Trust Plc (LON:IVI – Get Free Report)’s share price passed below its 50 day moving average during...
Watchstone Group (LON:WTG) Shares Cross Below 50-Day Moving Average – Should You Sell?
Shares of Watchstone Group plc (LON:WTG – Get Free Report) passed below its fifty day moving average during trading on...